Ophthalmology · New York, NY
NPI
1184732885
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
99 Elizabeth Street, 2fl
New York, NY, 10013
Phone (212) 227-8837
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
1,057 services
Medicare patients, 2024
205
Average age 76
Drug cost, 2024
$3.8M
11,587 prescriptions
Company payments, 2025
$3,705
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nancy N Tsai was code 92020 (ophthalmological e&m), 147 times for 147 patients. In total Nancy N Tsai billed 1,057 services in 30 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92020 Ophthalmological E&M | Office | 147 | 147 | $21.21 | $3,119 |
| 92202 Ophthalmological E&M | Office | 144 | 140 | $12.20 | $1,757 |
| 92083 Vision, Hearing, and Speech Services | Office | 126 | 123 | $55.09 | $6,941 |
| 99213 Office E&M - Established | Office | 106 | 95 | $71.56 | $7,586 |
| 92133 Computerized Ophthalmic Imaging | Office | 90 | 89 | $26.35 | $2,371 |
| 92250 Angiography | Office | 84 | 83 | $25.85 | $2,171 |
| 92014 Ophthalmological E&M | Office | 66 | 65 | $88.92 | $5,869 |
| 92134 Computerized Ophthalmic Imaging | Office | 54 | 52 | $32.39 | $1,749 |
| 99214 Office E&M - Established | Office | 45 | 45 | $97.62 | $4,393 |
| 99212 Office E&M - Established | Office | 41 | 32 | $43.56 | $1,786 |
| 92012 Ophthalmological E&M | Office | 25 | 25 | $41.41 | $1,035 |
| 99204 Office E&M - New | Office | 21 | 21 | $130.30 | $2,736 |
| 92004 Ophthalmological E&M | Office | 15 | 15 | $86.17 | $1,293 |
| 76519 Ultrasound - Nonspecific | Office | 12 | 12 | $61.00 | $732 |
| 66984 Cataract Surgery | Facility | 12 | 12 | $434.58 | $5,215 |
By year: 2022 $108K for 1,729 services; 2023 $72K for 1,287 services; 2024 $59K for 1,057 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nancy N Tsai prescribed most often to Medicare patients was Restasis (Cyclosporine), with 3,221 prescriptions and refills. In total Nancy N Tsai wrote 11,587 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 3,221 | 3,421 | 826 | $2.1M |
| Azelastine Hcl Generic | 1,724 | 1,778 | 385 | $25K |
| Bepotastine Besilate Generic | 1,029 | 1,466 | 269 | $186K |
| Latanoprost Generic | 773 | 1,175 | 190 | $6,339 |
| Xiidra Lifitegrast | 607 | 635 | 168 | $432K |
| Lumigan Bimatoprost | 426 | 508 | 77 | $123K |
| Brimonidine Tartrate Generic | 376 | 736 | 174 | $39K |
| Cyclosporine Generic | 366 | 461 | 110 | $113K |
| Prednisolone Acetate Generic | 363 | 716 | 262 | $17K |
| Vyzulta Latanoprostene Bunod | 219 | 244 | 39 | $59K |
| Bepreve Bepotastine Besilate | 217 | 298 | 74 | $96K |
| Ciprofloxacin Hcl Generic | 202 | 203 | 160 | $2,434 |
| Alphagan P Brimonidine Tartrate | 182 | 351 | 53 | $77K |
| Ketorolac Tromethamine Generic | 178 | 232 | 118 | $5,512 |
| Timolol Maleate Generic | 173 | 354 | 46 | $1,882 |
Brand drugs: 7,610 claims; generic drugs: 3,977 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nancy N Tsai $3,705 ($3,705 in general payments such as food, travel and fees) from 16 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $668.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 20 | $668 |
| Bausch & Lomb Americas Inc. BLCO | 9 | $484 |
| LENSAR, Inc. LNSR | 1 | $358 |
| Amgen Inc. AMGN | 16 | $355 |
| Lumenis BE inc | 1 | $321 |
| Alcon Vision LLC ALC | 13 | $286 |
| Biotissue Holdings Inc. | 3 | $275 |
| Dompe US, Inc. | 6 | $221 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 4 | $216 |
| Abbvie Inc. ABBV | 9 | $187 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.